Planta Med 2016; 82 - PC32
DOI: 10.1055/s-0036-1578734

In Vitro Anti-Infective Screening Of Selected West African Medicinal Plants

VO Imieje 1, 2, PS Fasinu 2, KO Ogbeide 1, NO Egiebor 3, A Falodun 1
  • 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benin, Benin City, 300001, Nigeria
  • 2National Center for Natural Products Research
  • 3Office of Global Engagement, University of Mississippi, University MS, 38677, USA

Individual or whole parts of Persea Americana, Caesalpinia bonduc and Caesalpinia pulcherrima have been traditionally used for the treatment of various infectious diseases in West Africa. Methanolic extracts and fractions of these plants were screened for in vitro activity against L. donovani (promastigotes, axenic amastigotes and intracellular amastigotes in THP1 cells), T. brucei, Plasmodium falciparum (chloroquine sensitive and chloroquine resistant strains) and selected pathogenic microbes. With IC50 values less than 10 µg/mL, the extracts exhibited selective antileishmanial activity against, L. donovani Amastigote, and less potent effects against L. donovani Promastigote, L. donovani Amastigote + THP, and T. brucei blood stage trypamastigotes. Fractions of P. Americana and C. pulcherrima showed strong activities against both chloroquine-sensitive and chloroquine-resistant strains of P. falciparum. With IC50 values ranging from 3.6 to 12 µg/mL, all fractions of C. pulcherrima exhibited significant antimicrobial activity especially against C. glabrata, C. krusei, S. aureus and P. aeruginosa (IC50 < 8 – 81 µg/mL). Crude extracts of P. Americana showed activity against C. glabrata, S. aureus and P. aeruginosa (IC50 22 – 86 µg/mL). These findings are important scientific support for traditional uses of these plants in infectious diseases and provide a strong basis for further studies towards anti-infective drug discovery from the plants.

Acknowledgements: This work was in part supported by USAID/HED grant 153 – 6200BF A-15 – 01 to Prof A. Falodun, University of Benin.